Bleeding and other vascular complications can have a substantial economic impact on costs for hospitals, adding incremental cost and increased length of stay based on severity. Cardiva products offer a safe and effective alternative to manual compression for femoral access site closure.
VASCADE has demonstrated enhanced safety and efficacy, helping to minimize complications and maximize hospital efficiencies. VASCADE optimizes vascular access management through:
In studies, Cardiva CATALYST Manual Compression Assist Device have shown to improve time to ambulation (TTA) and time to hemostasis (TTH), making the process more efficient for hospital staff and more comfortable for patients.